H-05(Protheragen)

N/A

Report date: 2025/08/13 13:35:57
NME

Base Information

Drug NameH-05(Protheragen)
Drug Alias NameH-05(Protheragen)
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionCapsid protein inhibitors
TargetsCapsid protein
Therapy Area/IndicationsHepatitis B
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesProtheragen Inc
China Registration ClassN/A

Develop Information

Active CompaniesProtheragen Inc
Inactive CompaniesN/A
Active IndicationsHepatitis B
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A